Zusammenfassung
Ein erheblicher Anteil der gesamten modernen Medizin ist heute bereits mit der Versorgung alter Menschen beschäftigt. Durch die Veränderungen der Altersstruktur in den kommenden Jahrzehnten ist damit zu rechnen, dass diese Aufgabe besonders im Bereich der Nervenheilkunde zunehmend anwachsen wird. Ältere Patien ten sind dabei nicht notwendigerweise besser compliant als Jüngere, sondern zählen wegen einer of mals skeptischen oder etwas eigensinnigen Grundhaltung gegenüber modernen Interventionen, wegen ihrer Unkenntnis, oder einer beeinträchtigten Fähigkeit, notwendige Grundregeln der Medikamenteneinnahme zu beherzigen, nicht selten zu dem schwierigeren Klientel. Aufgrund somatischer und psychischer Besonderheiten alter Menschen kann die psychopharmakologische Behandlung daher eine besondere Herausforderung darstellen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agüero-Torres, Kivipelto M, Von Strauss E (2006) Rethinking the dementia diagnosis in a populationbased study: what is Alzheimer’s disxease and what is vasclar dementia? Dement Geriat Cogn dis 22: 244–9
Alexopoulos G, Katz I, Cf R et al. (2001) Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 7: 361–376
Alexopoulos G, Katz I, Reynolds C et al. (2001) The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med Spec Vol: 1–86
Amrein R, Stabl M, Henauer S et al. (1997) Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective sero tonin reuptake inhibitors in elderly depressed patients: a clinical overview. Can J Psychiatry 42: 1043–50
Ancelin ML, Artero S, Portet F et al. (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455–459
Aziz R, Lorberg B, Tampi R (2006) Treatments for late-life bi polar disorder. Am J Geriatr Psychiatry 4: 347–364
Bak S, Tsiropoulos Ikjaersgaard JO, Andersen M et al. (2002) Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population-Based Case-Control Study. Stroke 33: 1465–1473
Barak Y, Olmer A, Aizenberg D (2006) Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology 31: 178–181
Beers M (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Int Med 157: 1531–1536
Bondareff W, Alpert M, Friedhoff A et al. (2000) Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late-life. Am J Psychiatry 157: 729–736
Calabrese P, Essner U, Förstl H (2007) Memantine in clinical practice. Dement Geriatr Cogn Dis 24: 111–117
Czekalla J, Walker S, Beasley CM (2001) Cardiac safety parameters of olanzapine. Comparison with other atypical and typical antipsychotics. J Clin Psychiatry 62(S2): 35–40
Devanand D, Pelton G, Marston K et al. (2003) Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatric Psychiatry 18: 123–130
Diehl J, Ernst J, Krapp S et al. (2006) Frontotemporale Demenz und delinquentes Verhalten. Fortschr der Neurol Psychiat 74: 203–210
Eastham JH, Jeste DV, Young RC (1998) Assessment and treatment of bipolar disorder in the elderly. Drugs Aging 12: 205–224
Edwards JG, Anderson I (1999) Systematischer Überblick und Leitfaden für die Auswahl selektiver Serotonin-Wiederaufnahmehemmer. Drugs 57: 507–533
Egert S, Wagenpfeil S, Förstl H (2007) Cholinesterase-Inhibitoren und Alzheimer Demenz: Metaanalyse zu Wirksamkeitsnachweis, Ursprung und Ergebnisverzerrung in publizierten Studien. DMW 132: 1207–1213
Finkel S (2005) Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. International Psychogeriatrics 17: 617–629
Flint AJ, Rifat SL (1996) The effenct of sequential antidepressant treatment on geriatric depression. J Affect Disord 36: 95–105
Flint AJ, Rifat SL (1999) Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants. Am J Psychiatry 156: 943–5
Flint AJ, Rifat SL (2008) Maintenance treatment for recurrent depression in late life. A four-year outcome study. Am J Geriatr Psychiatry 8: 112–6
Förstl H (2008a) Antidementiva — wem nützen sie wirklich? Internist 49: 353–359
Förstl H (2008b) Behandlungs-und Versorgungsstrategien bei Alzheimer und verwandten Demenzen. Nervenarzt 79: 617–629
Förstl H, Bickel H, Frölich L et al. (2008a) MCI-plus: leichte kognitive Störungen mit Vorzeichen rascher Verschlechterung. DMW 133431–436
Förstl H, Gratz S, Hahn U et al. (2008) Demenz mit Lewy-Körperchen und verminderter Dopamin-Transporter-Bindung verweist auf Azetylcholin-Mangel. Dtsch Med Wochenschr, 133 Suppl. 1: 11–14
Gill SS, Bronskill SE, Normand SL et al. (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Int Med 146: 775–786
Gorwood P, Weiller E, Lemming O et al. (2007) Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 15: 581–593
Heeren T, Derksen P, Van Heycop Ten Ham B et al. (1997) Treatment, outcome and predictors of response in elderly depressed in-patients. Br J Psychiatry 170: 436–440
Hegerl U, Möller H (1996) Nortriptylin. Stellenwert in der psychiatrischen Pharmakotherapie. Psychopharmakotherapie 3: 13–27
Hegerl U, Henkel V (2002) Behandlung von Altersdepressionen und multimorbiden Patienten. In: Riederer P, Laux G, Pöldinger W, editors. Neuro-Psychopharmaka. Bd. 3 Antidepressiva Ein Therapie-Handbuch. 2. Aufl. ed. Wien, Springer, S 662–679
Ibor J, Carrasco J, Prieto R et al. (2008) Effectiveness and sa fety of venlafaxine extended release in elderly depressed patients. Arch Gerontol Geriatr 46: 317–326
Jacobson S, Pies R, Katz I (2007) Clinical manual of geriatric psychopharmacology. Washington: American Psychiatric Publ
Katona C, Bercoff E, Chiu E et al. (1999) Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial. J Affect Disord 55: 203–213
Katona C, Livingston G (2002) How well do antidepressants work in older people? A systematic review of number needed to treat. J Affect Disord 69: 47–52
Kok R, Nolen W, Heeren T (2007) Venlafaxine versus nortripty line in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. Int J Geriatric Psychiatry 22: 1247–1254
Kornhuber J, Bormann J, Retz W et al. (1989) Memantine displaces [3H]MK-801 at therapeutic concen-trations in postmortem human frontal cortex. Eur J Pharmacol 166: 589–590
Kornhuber J, Bormann J, Hübers M et al. (1991) Effects of the 1-amino-adamantanes at the MK-801-bindig site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Eur J Pharmacol 206: 297–300
Lasser R, Siegel E, Dukoff R et al. (1998) Diagnosis and treatment of geriatric depression. CNS Drugs 9: 17–30
Lautenschlager MM, Lautenschlager NT, Förstl H, (2008) Psychopharmaka im Alter. In: Handbuch der Psychopharmakotherapie. Hrsg. F. Holsboer, G. Gründer, O. Benkert. Springer, S 1081–1092
Laux G, Dietmaier O (2006) Praktische Psychopharmakotherapie. 5. Aufl. München, Elsevier Urban & Fischer
Liperoti J, Gambassi G, Lapane KL et al. (2005) Cerebrovascular events among elderly patients treated with conventional and atypical antipsychotics. J Clin Psychiatry 66: 1090–1096
Mazeh D, Shahal B, Aviv A et al. (2007) A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. Int Clin Psychopharmacol 22: 371–375
Menting J, Honig A (1996) Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int. Clin. Psychopharmacol 11: 165–175
Mulsant B, Pollock B, Nebes R et al. (2001) A twelve-week, double-blind randomized comparison of nortriptyline and paroxetine in older depressed patients and outpatients. Am J Geriatr Psychiatry 9: 406–414
Nair NP, Amin M, PH et al. (1995) Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo. J Affect Disord 33: 1–9
Navarro V, Gasto C, Torres X et al. (2001) Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatr Scand 103: 435–440
Nelson J, Wohlreich M, Mallinckrodt C et al. (2005) Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry 13: 227–235
Newhouse PA (1996) Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 57(Suppl 5): 12–22
Newhouse PA, Krishnan KR, Doraiswamy PM et al. (2000) A double blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 61: 559–568
Ollendorf DA, Joyce AT, Rucker M (2004) Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. Med Gen Med 6: 5
Oslin D, Ten Have T, Streim J et al. (2003) Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry 64: 875–882
Rampello L, Chiechio S, Nicoletti G et al. (2004) Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 173: 73–78
Rampello L, Alvano A, Chiechio S et al. (2005) An evaluation of efficacy and safety of reboxetine in elderly patients affected by „retarded„ post-stroke depression. A random, placebo-controlled study. Arch Geront Geriatr 40: 275–285
Richards J, Papaioannou A, Adachi J et al. (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167: 188–194
Riederer P, Lange KW, Kornhuber J, Danielczyk W (1991) Pharmacotoxic psychosis after memantine in Parkinson’s disease. Lancet 388: 1022–1023
Robinson RG (2003) Poststroke depression: prevalence, diagnosis, treatment and disease progression. Biol Psychiatry 54: 376–387
Rochon PA, Normand SL, Gomes T et al. (2008) Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 168: 1090–1096
Roose S, Sackeim H, Krishnan K et al. (2004) Antidepressant pharmacotherapy in the treatment of depression in the very old:a randomized, placebo-controlled trial. Am J Psychiatry 161: 2050–2059
Roose S, Pollock B, Devanand D (2004) Treatment during late life. In: Schatzberg A, Nemeroff CB, editors. Textbook of psychopharmacology. 3. ed Washington: American Psychiatric Publishing
Sajatovic M (2000) Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry 17: 865–73
Schatzberg A, Kremer C, Rodrigues H et al. (2002) Double-blind randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 10: 541–550
Schatzberg A, Roose S (2006) A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry 14: 361–370
Schneeweiss S, Patrick AR, Stürmer T et al. (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. Canad Med Assoc J 176: 627–632
Schneider L, Nelson J, Clary C et al. (2003) An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160: 1277–1285
Sheikh J, Cassidy E, Doraiswamy P et al. (2004) Efficacy, safety, and tolerability of sertraline in patients with late-life depression and co-morbid medical illness. J Am Geriatr Soc 52: 86–92
Sink KM, Holden K, Yaffe K (2005) Pharmacological treatment of neuropsychiatric symptoms of dementia. JAMA 293: 596–608
Solai L, Mulsant B, Pollock B (2001) Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging 18: 355–368
Steiner D, Marcopulos B (1991) Depression in the elderly. Characteristics and clinical management. Nurs Clin North Am 26: 585–600
Targum SD, Abbot JL (2000) Efficacy of quetiapine in Parkinson’s patients with psychosis. J Clin Psychopharmacology 20: 54–60
Tariot PN, Salzman C, Yeung PP, Pultz J, Rak IW (2000) Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Therapeutics 22: 1068–1084
Tariot PN, Farlow MR, Grossberg GT et al. (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291: 317–24
Taylor DM (2003) Antipsychotics and QT prolongation. Acta Psychiatr Scand: 107: 85–95
Volz HP, Gleiter CH (1998) Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drugs Aging 13: 341–55
Wang P, Schneeweiss D, Brookhart M et al. (2005) Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol 25: 118–126
Weihs K, Settle E, Batey S et al. (2000) Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 61: 196–202
Whyte E, Basinski J, Farhi P et al. (2004) Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65: 1634–1641
Wise T, Wiltse C, Iosifescu D et al. (2007) The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract 61: 1283–1293
Wu E, Greenberg P, Yang E et al. (2008) Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population. Curr Med Res Opin 24: 2587–2595
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Förstl, H., Lautenschlager, M.M., Lautenschlager, N.T., Laux, G. (2010). Psychopharmaka in Geriatrie und Gerontopsychiatrie. In: Riederer, P.F., Laux, G. (eds) Grundlagen der Neuro-Psychopharmakologie. Springer, Vienna. https://doi.org/10.1007/978-3-211-85473-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-211-85473-0_17
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-85472-3
Online ISBN: 978-3-211-85473-0
eBook Packages: Medicine (German Language)